2xqf: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_2xqf| PDB=2xqf | SCENE= }} | {{STRUCTURE_2xqf| PDB=2xqf | SCENE= }} | ||
===X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VX=== | ===X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VX=== | ||
{{ABSTRACT_PUBMED_21454498}} | |||
==Disease== | |||
[[http://www.uniprot.org/uniprot/CHLE_HUMAN CHLE_HUMAN]] Defects in BCHE are the cause of butyrylcholinesterase deficiency (BChE deficiency) [MIM:[http://omim.org/entry/177400 177400]]. BChE deficiency is a metabolic disorder characterized by prolonged apnoea after the use of certain anesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency. BChE deficiency is a multifactorial disorder. The hereditary condition is transmitted as an autosomal recessive trait. | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/CHLE_HUMAN CHLE_HUMAN]] Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters.<ref>PMID:19542320</ref><ref>PMID:19452557</ref> | |||
==About this Structure== | ==About this Structure== | ||
| Line 22: | Line 13: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:021454498</ref><references group="xtra"/> | <ref group="xtra">PMID:021454498</ref><references group="xtra"/><references/> | ||
[[Category: Cholinesterase]] | [[Category: Cholinesterase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 32: | Line 23: | ||
[[Category: Noort, D.]] | [[Category: Noort, D.]] | ||
[[Category: Wandhammer, M.]] | [[Category: Wandhammer, M.]] | ||
[[Category: Bioscavenger]] | |||
[[Category: Hydrolase]] | |||
[[Category: Nerve agent]] | |||